The US FDA is looking to get out in front of potential misuse and abuse in its review of Charleston Laboratories Inc.'s non-abuse-deterrent opioid Hydexor (hydrocodone, acetaminophen and promethazine), as the agency is proactively exploring trends and patterns on online drug forums in advance of the drug's advisory committee meeting.
The agency's Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee will meet in...